BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 12948256)

  • 41. Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature.
    Trébucq A
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):12-5. PubMed ID: 9441051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of toxic optic neuropathy with low-dose ethambutol.
    Yang HK; Park MJ; Lee JH; Lee CT; Park JS; Hwang JM
    Int J Tuberc Lung Dis; 2016 Feb; 20(2):261-4. PubMed ID: 26792482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ethambutol/Linezolid Toxic Optic Neuropathy.
    Libershteyn Y
    Optom Vis Sci; 2016 Feb; 93(2):211-7. PubMed ID: 26636399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study.
    Kanaujia V; Jain VK; Sharma K; Agarwal R; Mishra P; Sharma RK
    Can J Ophthalmol; 2019 Jun; 54(3):301-305. PubMed ID: 31109468
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ethambutol and the optic nerve].
    Hamard H
    Bull Soc Ophtalmol Fr; 1989; 89(8-9):1001-3. PubMed ID: 2620414
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Visually evoked cortical potentials for early detection of optic neuritis in ethambutol therapy].
    Dette TM; Spitznas M; Göbbels M; Koch F; Leinhos C
    Fortschr Ophthalmol; 1991; 88(5):546-8. PubMed ID: 1757046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The incidence of optic neuropathy in 84 patients treated with ethambutol.
    De Palma P; Franco F; Bragliani G; Michetti L; Marescotti A; Pirazzoli G; Fiorenza M
    Metab Pediatr Syst Ophthalmol (1985); 1989; 12(1-3):80-2. PubMed ID: 2770528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ethambutol tolerance during hospital and outpatient treatment of patients with pulmonary tuberculosis].
    Rudoĭ NM; Eĭsaev BA
    Ter Arkh; 1975; 47(1):53-6. PubMed ID: 1114448
    [No Abstract]   [Full Text] [Related]  

  • 49. Drastically Progressive Ethambutol-induced Optic Neuropathy after Withdrawal of Ethambutol: A Case Report and Literature Review.
    Matsumoto T; Kusabiraki R; Arisawa A; Fujiki T; Noda A; Tanaka A; Yamamoto N; Aihara K; Yamaoka S; Mishima M
    Intern Med; 2021 Jun; 60(11):1785-1788. PubMed ID: 33390493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multifocal electroretinographic abnormalities in ethambutol-induced visual loss.
    Liu Y; Dinkin MJ; Loewenstein JI; Rizzo JF; Cestari DM
    J Neuroophthalmol; 2008 Dec; 28(4):278-82. PubMed ID: 19145124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re-Treatment With Ethambutol After Toxic Optic Neuropathy.
    Bouffard MA; Nathavitharana RR; Yassa DS; Torun N
    J Neuroophthalmol; 2017 Mar; 37(1):40-42. PubMed ID: 27636749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Bitemporal hemianopia as presenting sign of severe ethambutol toxicity].
    Boulanger Scemama E; Touitou V; Le Hoang P
    J Fr Ophtalmol; 2013 Nov; 36(9):e163-7. PubMed ID: 24094504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visual Recovery Time in Patients with Ethambutol-induced Toxic Optic Neuropathy.
    An HR; Lee BJ; Moon Y
    Korean J Ophthalmol; 2024 Apr; 38(2):91-97. PubMed ID: 38351490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Leber's hereditary optic neuropathy masquerading as ethambutol-induced optic neuropathy in a young male.
    Chowdhury B; Nagpaul AK; Chowdhury D
    Indian J Ophthalmol; 2006 Sep; 54(3):218-9. PubMed ID: 16921234
    [No Abstract]   [Full Text] [Related]  

  • 55. Toxic ocular effects of ethambutol.
    Kahana LM
    CMAJ; 1987 Aug; 137(3):213-6. PubMed ID: 3607664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Severe and reversible optic neuropathy by ethambutol and isoniazid].
    Rodríguez-Marco NA; Solanas-Alava S; Ascaso FJ; Martínez-Martínez L; Rubio-Obanos MT; Andonegui-Navarro J
    An Sist Sanit Navar; 2014; 37(2):287-91. PubMed ID: 25189987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on ethambutol optic neuropathy.
    Fraunfelder FW; Sadun AA; Wood T
    Expert Opin Drug Saf; 2006 Sep; 5(5):615-8. PubMed ID: 16907651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethambutol optic neuropathy.
    Chamberlain PD; Sadaka A; Berry S; Lee AG
    Curr Opin Ophthalmol; 2017 Nov; 28(6):545-551. PubMed ID: 28759559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Color vision in 42 Congolese patients with tuberculosis receiving ethambutol treatment.
    Kaimbo WK; Bifuko ZA; Longo MB; Dralands L; Missotten L
    Bull Soc Belge Ophtalmol; 2002; (284):57-61. PubMed ID: 12161991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.